Main Navigation
 
Search
Advanced Search>>
Free Newsletter
Subscribe
Unsubscribe
 
 
  
Health Headlines

Get the latest news in prevention and health matters. This feature includes daily postings and recent archives to keep you up to date on health reports and wires around the world.
Weekly Wellness
Get informed with weekly wellness facts in a diversity of health topics from prevention to fitness and nutrition.
Tips
Great tips on what you need to know about keeping healthy and active all year round.

 

Creatine Use Could Lead to Cancer

PARIS (Reuters) - Creatine, a dietary supplement used by many athletes to increase muscle bulk, could lead to cancer, a French government agency said on Wednesday.

The French Agency of Medical Security for Food (AFSSA) said in a report published on its Internet site that the use of creatine ``constitutes a risk that has not been sufficiently evaluated, particularly in the long term''.

The report said there is a ``potential carcinogenic risk'' for users of the product, which is sold over the counter in many countries and is not banned by the International Olympic Committee. It is often described as a ``legal steroid''.

The AFSSA report quoted epidemiologic studies that showed creatine causing ``digestive, muscular and cardiovascular problems.''

The report also said the use of creatine should be regarded ''as contrary to the rules, spirit and significance of sport'' and suggested consideration should be given to it being added to the list of banned products.

Former French rugby coach Pierre Berbizier created a storm last month when he said the use of creatine was common in the French championship.

The dietary supplement has been used by many leading sports people, including French tennis player Mary Pierce and baseball player Mark McGwire.

The sale of creatine is banned in France, however, and it is also banned by the French Rugby Union.

Reference Source 89

For more information on how to prevent obesity or diabetes, use
PreventDisease.com's "Quick Prevention Resources".

Select a Channel